GlassScriptPhysician profile
Sandeep Kaur
NPI 1316671902
$1,858.42
in general payments reported to CMS, 2019-2025
16 companies · $608 in 2025
The $608 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $25.89 · 2023: $403 · 2024: $821 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,832.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $501.72 | 2023-2025 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $350.36 | 2023-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $271.63 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $137.14 | 2023-2025 | Mounjaro, Jardiance, Emgality |
| Otsuka America Pharmaceutical, INC. | $128.46 | 2023-2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.23 | 2023-2025 | Jardiance |
| Pfizer INC. | $52.20 | 2023-2025 | |
| Novo Nordisk INC | $51.46 | 2024-2025 | Rybelsus, Ozempic |
| Phathom Pharmaceuticals, INC. | $51.19 | 2024-2025 | Voquezna |
| Irhythm Technologies, INC. | $45.68 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Exact Sciences Corporation | $42.27 | 2023-2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $27.31 | 2024 | Gemtesa |
| Vanda Pharmaceuticals INC. | $25.89 | 2022 | |
| Eisai INC. | $22.82 | 2025 | |
| Dexcom, INC. | $19.22 | 2024 | Dexcom G6 Transmitter |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $15.84 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.